Hennion & Walsh Asset Management, Inc. - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 121 filers reported holding IMMUNOVANT INC in Q4 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
Hennion & Walsh Asset Management, Inc. ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$5,492,841
+168910.5%
143,080
-16.5%
0.35%
+81.3%
Q2 2023$3,250
-7.9%
171,328
-24.7%
0.19%
-10.6%
Q1 2023$3,529
-21.6%
227,556
-10.3%
0.22%
-22.3%
Q4 2022$4,502
-99.6%
253,636
+10.4%
0.28%
+231.0%
Q3 2022$1,282,000
+39.3%
229,675
-2.7%
0.08%
+47.4%
Q2 2022$920,000
-24.5%
235,997
+6.7%
0.06%
-12.3%
Q1 2022$1,218,000
-11.1%
221,136
+37.5%
0.06%
-3.0%
Q4 2021$1,370,000
+138.3%
160,800
+143.1%
0.07%
+123.3%
Q3 2021$575,000
+25.0%
66,142
+52.1%
0.03%
+20.0%
Q2 2021$460,00043,5000.02%
Other shareholders
IMMUNOVANT INC shareholders Q4 2021
NameSharesValueWeighting ↓
Alpine Global Management, LLC 3,007,000$25,620,0003.77%
Deep Track Capital, LP 4,775,000$40,683,0002.87%
Octagon Capital Advisors LP 572,862$4,881,0000.95%
Eventide Asset Management 4,950,000$42,174,0000.54%
WITTENBERG INVESTMENT MANAGEMENT, INC. 140,500$1,197,0000.44%
FRAZIER MANAGEMENT LLC 585,759$4,991,0000.38%
MANGROVE PARTNERS IM, LLC 688,000$5,862,0000.35%
BCK CAPITAL MANAGEMENT LP 54,293$463,0000.31%
EcoR1 Capital, LLC 1,140,819$9,720,0000.31%
MANGROVE PARTNERS IM, LLC 570,400$4,860,0000.29%
View complete list of IMMUNOVANT INC shareholders